Cocaine Rewires Your Gut Bacteria to Deplete Glycine and Fuel Addiction, Study Finds
Cocaine doesn't just rewire the brain. Preliminary research suggests it may first disrupt the gut, triggering a bacterial cascade that strips the body of a key neurotransmitter precursor and amplifies drug-seeking behavior.
Cocaine doesn't just alter brain chemistry directly. According to a new mouse study published in June 2026, the drug may trigger a cascade that begins in the gut, promotes the overgrowth of specific bacteria, and ultimately depletes a key amino acid that shapes how the brain's reward circuitry responds to the drug. If these findings hold up beyond rodent models, they could open an entirely new front in addiction treatment.
Cocaine Exposure Expands Gut Proteobacteria and Depletes Glycine
The study by Delgado Ocaña and colleagues found that cocaine exposure in mice consistently increased the abundance of gut Proteobacteria, a bacterial phylum that includes common species like Escherichia coli. This microbial shift had a downstream consequence: the expanded Proteobacteria population consumed host glycine, an inhibitory neurotransmitter and amino acid with roles throughout the nervous system, leaving circulating glycine levels depleted.
To isolate the mechanism, the researchers used human Escherichia coli HS as a model Proteobacteria strain, alongside a glycine-uptake-deficient mutant called E. coli HS ΔCycA, which cannot absorb glycine. Comparing mice colonized with each strain allowed the team to attribute specific behavioral and molecular differences directly to bacterial glycine consumption, rather than to other effects of bacterial colonization. This mechanistic precision is one of the study's more compelling methodological features.
The finding builds on earlier work showing that cocaine elevates intestinal norepinephrine, activating the QseC receptor in gamma-Proteobacteria and promoting their colonization, which then consume glycine and potentiate cocaine-induced behavioral responses. The new study extends that picture by tracing the effects all the way to the nucleus accumbens proteome and to a translational self-administration paradigm.
Glycine Depletion Reshapes the Nucleus Accumbens and Amplifies Drug Seeking
The nucleus accumbens (NAc), a brain region central to reward, motivation, and the reinforcing effects of drugs, showed clear molecular changes in glycine-depleted mice. Bacterial-induced glycine depletion altered cocaine-induced transcriptional activity in the NAc and affected the NAc proteome, the full complement of proteins the region expresses, at multiple stages of a cocaine self-administration paradigm.
Behaviorally, glycine depletion facilitated behavioral sensitization (an escalating response to repeated cocaine exposure) and conditioned place preference, a measure of how strongly an animal associates a location with a drug's rewarding effects. Crucially, the gut bacteria's ability to consume glycine also shaped the reinstatement of cocaine self-administration, a rodent model used to approximate relapse in human psychostimulant use disorders. Mice whose gut Proteobacteria could deplete glycine showed greater vulnerability to drug-seeking behavior across the self-administration stages, suggesting the bacterial-glycine axis influences not just initial drug response but longer-term patterns of motivation and relapse.
This is preliminary, investigational research, and the behavioral models, while considered translational for addiction research, are still rodent proxies for human phenomena. That said, the mechanistic specificity achieved using the ΔCycA mutant gives the findings more weight than an observational microbiome correlation study would.
Why the Gut-Brain Axis Matters for Addiction Research
The broader field has been building toward this kind of finding for years. Research examining the microbiome-gut-brain axis as a therapeutic target for substance-related disorders has identified the gut microbiome as a plausible contributor to the onset and progression of addiction, though causal evidence in humans remains limited. Separately, microbial glutamate metabolism has been linked to cocaine self-administration predisposition in diversity outbred mice, pointing to amino acid metabolism in the gut as a recurring theme in addiction neuroscience.
What makes the current study distinctive is its focus on a specific microbial phylum, a specific amino acid, and a specific brain region, connected through a testable mechanism rather than a statistical association. The Proteobacteria phylum, the researchers argue, is a crucial factor shaping both short- and long-term neurobehavioral adaptation during cocaine exposure.
Limitations: Mice, Mechanism, and the Road to Humans
The study is mouse-only, and important caveats apply. Gut microbiome research more broadly faces limitations including confounding variables, limited sample diversity, and cross-sectional designs that restrict causal inference. This study addresses the causality problem more directly than most, using genetic bacterial mutants to isolate glycine metabolism as the relevant variable, but it cannot yet tell us whether the same mechanism operates in humans with cocaine use disorder.
The scope of the NAc proteome findings also raises follow-up questions the paper does not fully resolve: which specific proteins change, which molecular pathways are most affected, and whether the changes are reversible with glycine restoration. These are the kinds of mechanistic details that future studies will need to fill in before any clinical translation becomes plausible.
Glycine Supplementation as a Possible Intervention
The most immediately testable implication of these findings is straightforward: if bacterial glycine consumption is driving molecular changes that amplify cocaine-seeking, restoring glycine levels might disrupt that cycle. Early reporting on related research has highlighted glycine supplementation as a candidate intervention that could potentially interrupt the Proteobacteria-driven pathway before it reshapes the NAc.
That is speculative for now, and significant translational work would be needed before glycine supplementation or Proteobacteria-targeting strategies could be evaluated in clinical trials. Current FDA-approved treatments for cocaine use disorder remain limited, and new mechanistic leads are genuinely valuable even at this early stage. The authors frame the gut microbiome, and the Proteobacteria phylum specifically, as a factor influencing motivation and cocaine-seeking behaviors that the addiction field has largely overlooked. Whether that framing survives translation to humans is the central open question their findings raise.
Evidence rating
INVESTIGATIONAL — 75/100
Caveats:
- All findings are from mouse models only — no human data exists yet.
- Funding was not disclosed by the authors, so independent verification of this study's support cannot be confirmed.
- This builds on the same research group's prior work; independent replication by separate labs has not yet been reported.
Mouse-only preclinical study using engineered E. coli strains to isolate the effect of bacterial glycine metabolism on cocaine-related neuroplasticity. Demonstrates a step-by-step mechanistic chain but cannot establish human relevance. Builds on prior work from the same research group; independent replication has not yet been reported.
References
- Susana Delgado Ocaña, Guadalupe Herrera, Daniel Guzmán, David W. Self, Santiago Cuesta (2026). Gut Proteobacteria glycine metabolism regulates neuroplasticity, motivation, and reinstatement of cocaine self-administration in mice. Gut Microbes. https://doi.org/10.1080/19490976.2026.2693397
- Yiping Ru, Jie Jia, Xiyao Yang, et al. (2025). From bugs to behavior: targeting the gut-brain interface for addiction therapeutics. Gut Microbes. https://doi.org/10.1080/19490976.2025.2569740
- The Microbiome–Gut–Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525790/
- Thi Dong Binh Tran, Hoan Nguyen, Erica Sodergren, et al. (2023). Microbial glutamate metabolism predicts intravenous cocaine self-administration in diversity outbred mice. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2022.109409
- Alejandro Borrego-Ruiz, Juan J. Borrego (2025). The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis. Life. https://doi.org/10.3390/life15060834
- Brain-gut connection may reveal way to prevent cocaine addiction. news.wisc.edu. https://news.wisc.edu/brain-gut-connection-may-reveal-way-to-prevent-cocaine-addiction/